1. Home
  2. Sistema de Salut de Catalunya
  3. Vall d'Hebron Hospital Universitari – HVH
  4. Articles científics - HVH
  5. View Item

Brentuximab vedotin compared with historical controls for severe skin involvement in cutaneous systemic sclerosis

To access the full text documents, please follow this link: https://hdl.handle.net/11351/12737

Author

Fernández Codina, Andreu

Nevskaya, Tatiana

Baron, Murray

Appleton, Christopher Thomas

Cecchini, Matthew

Philip, Amanda

Other authors

Institut Català de la Salut

[Fernández-Codina A] Division of Rheumatology, Western University, London, ON, Canada. Division of General Internal Medicine-Windsor Campus, Western University, London, ON, Canada. Grup de Recerca de Reumatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Nevskaya T, Appleton CT, Philip A] Division of Rheumatology, Western University, London, ON, Canada. [Baron M] Division of Rheumatology, Jewish General Hospital, McGill University, Montreal, QC, Canada. [Cecchini MJ] Division of Pathology, Western University, London, ON, Canada

Vall d'Hebron Barcelona Hospital Campus

Publication date

2025-03-11T08:58:34Z

2025-03-11T08:58:34Z

2025-02



Share

Abstract

Severe skin involvement; Cutaneous systemic sclerosis

Afectació cutània; Esclerosi sistèmica cutània

Afectación cutánea; Esclerosis sistémica cutánea

Investigator-initiated study. Seagen provided partial funding and interpretation of the data. Seagen had courtesy access to the final manuscript, without having influence on the final publication.

Document Type

Article

Published version

Language

English

Subjects and keywords

Anticossos monoclonals - Ús terapèutic; Avaluació de resultats (Assistència sanitària); Esclerodèrmia - Tractament; Medicaments immunosupressors - Tractament; DISEASES::Skin and Connective Tissue Diseases::Connective Tissue Diseases::Scleroderma, Systemic; Other subheadings::Other subheadings::Other subheadings::/drug therapy; CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Immunologic Factors::Immunosuppressive Agents; Other subheadings::Other subheadings::/therapeutic use; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome; ENFERMEDADES::enfermedades de la piel y tejido conjuntivo::enfermedades del tejido conjuntivo::esclerodermia sistémica; Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia; COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::factores inmunitarios::inmunosupresores; Otros calificadores::Otros calificadores::/uso terapéutico; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento

Publisher

Oxford University Press

Related items

Rheumatology;64(2)

https://doi.org/10.1093/rheumatology/keae460

Recommended citation

This citation was generated automatically.

Export

DIDL MARC MARC_CCUC METS OAI_DC ORE QDC RDF

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)

Articles científics - HVH [3440]